基本信息
浏览量:131
职业迁徙
个人简介
After three years’ postdoctoral training in Department of Physiology and Biophysics at Case Western Reserve University (Cleveland, Ohio), she started her first faculty position as Assistant Professor of Physiology and Biophysics at University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School (Piscataway, NJ). In 2012, she joined Davis Heart and Lung Research Institute and Comprehensive Cancer Center at the Ohio State University Medical Center as Associate Professor. In the fall of 2016, she relocated her research group to the University of Texas at Arlington, College of Nursing and Health Innovation as Associate Professor with tenure.
Her research interest is focused on calcium signaling in cancer, muscle and heart diseases. Her discoveries include the identification of the physiological and pathophysiological roles of the store-operated calcium entry in skeletal muscle fatigue and a number of cancers, such as esophageal cancer. Dr. Pan’s current effort is to understand the precise mechanisms underlying the dysregulation of calcium channels in different diseases and to search for novel biomarkers for early detection or prognosis and therapeutic targets for patients. In particular, they identified Orai1, a calcium channel protein overexpressed in esophageal cancer tumor tissues as a potential chemotherapy target. As the principal investigator, her research has received multiple funding supports from National Institute of Health, American Diabetes Association, Pelotonia, Texas STARs Award as well as industry.
Her research interest is focused on calcium signaling in cancer, muscle and heart diseases. Her discoveries include the identification of the physiological and pathophysiological roles of the store-operated calcium entry in skeletal muscle fatigue and a number of cancers, such as esophageal cancer. Dr. Pan’s current effort is to understand the precise mechanisms underlying the dysregulation of calcium channels in different diseases and to search for novel biomarkers for early detection or prognosis and therapeutic targets for patients. In particular, they identified Orai1, a calcium channel protein overexpressed in esophageal cancer tumor tissues as a potential chemotherapy target. As the principal investigator, her research has received multiple funding supports from National Institute of Health, American Diabetes Association, Pelotonia, Texas STARs Award as well as industry.
研究兴趣
论文共 164 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGYno. 1 (2024): G38-G52
Frontiers in pharmacology (2023): 1149665
引用0浏览0WOS引用
0
0
Tissue engineering. Part C, Methodsno. 8 (2023): 349-360
Frontiers in oncology (2022): 1090583
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn